Your weekly roundup of the latest news from Drug Topics®.
Significant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors
The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.
Voxzogo is already available for patients over 5 years with a genetic cause of dwarfism. The PDUFA date is set for Oct. 21, 2023, and will potentially expand the drug to children 5 and under.
The drug, manufactured by Sandoz, will treat conditions including osteoporosis in postmenopausal women
The role of the pharmacy technician has evolved over the past 45 years—but pay hasn’t caught up